Global News

[ad_1] A New Jersey court has has thrown out a nearly $224 million verdict against Johnson & Johnson that was awarded to four people who alleged in a lawsuit that they got cancer from using the company's talcum-powder products.  The three-judge appeals court ordered a new trial after ruling that expert testimony presented in a lower court on behalf of the plaintiffs was faulty. J&J was ordered in 2019 to pay New Jersey residents Douglas Barden, David Etheridge, D'Angela McNeill-George and William Ronning $37.3 million, along with $186.5 million in punitive damages.  The company appealed that decision the following year, arguing that three experts selected to testify during the trial — William Longo, Jacqueline Moline and James Webber — presented flawed or incomplete information. Moline is an occupational medicine doctor at North Shore University Hospital in Long Island, New York. Longo is a materials scientist in Georgia, CEO of Micro Analytical Laboratories and a

[ad_1] Johnson & Johnson said Wednesday it has offered to pay $6.5 billion to settle allegations that its talc products caused cancer, a key step in the pharmaceutical giant potentially resolving decades of litigation over what was once one of the most widely used consumer products in the U.S. The proposal is aimed at ending a protracted legal battle stemming from thousands of lawsuits that accused J&J of selling products that allegedly led women to develop ovarian cancer, in some cases causing their death.  J&J maintains that its talc products  are safe . But the company stopped selling talc-based items in 2020, and two years later announced plans to cease sales of the product worldwide. The company  said  the proposal would settle 99.75% of the pending talc lawsuits in the U.S. The legal actions not covered by the proposal relate to mesothelioma, a rare cancer that affects the lungs and other organs. The company said